| VERTEX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US92532F1003 / 882807 |
| VX1 (Frankfurt) / VRTX (NASDAQ) |
| FRA:VX1, ETR:VX1, VX1:GR, NASDAQ:VRTX |
| https://www.vrtx.com/ |
|
Vertex Pharmaceuticals Incorporated is a leading biotechnology company founded in 1989 and headquartered in Boston, Massachusetts. It specializes in the discovery, development, and commercialization of transformative therapies, with a primary focus o..
>Volltext.. |
| 98430.1 Mio. EUR |
| 94536.54 Mio. EUR |
| 10460.4 Mio. EUR |
| 4303.76 Mio. EUR |
| 3424.72 Mio. EUR |
| 13.4 EUR |
| 1763.82 Mio. EUR |
| 4407.64 Mio. EUR |
| 3145.94 Mio. EUR |
| 1.71 |
| -3.11% |
| - |
| - |
| - |
| - |
| VERTEX PHARMACEUTICALS, VERTEX PHARMA, VRTX |
| 04.04.26 |
|